Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00641_DB04855> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00641_DB04855 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00641_DB04855 label "DDI between Simvastatin and Dronedarone - Dronedarone is a CYP2D6 inhibitor thus increasing serum concentrations of simvastatin 4-fold. Lower doses of simvastatin and doses should not exceed 20 mg to avoid statin-induced toxicities like myopathy. Consider rosuvastatin as cholesterol lowering therapy as there is no significant interaction between rosuvastatin and dronedarone. [drugbank_resource:DB00641_DB04855]" assertion.
- drugbank_resource:DB00641_DB04855 identifier "drugbank_resource:DB00641_DB04855" assertion.
- drugbank_resource:DB00641_DB04855 title "DDI between Simvastatin and Dronedarone - Dronedarone is a CYP2D6 inhibitor thus increasing serum concentrations of simvastatin 4-fold. Lower doses of simvastatin and doses should not exceed 20 mg to avoid statin-induced toxicities like myopathy. Consider rosuvastatin as cholesterol lowering therapy as there is no significant interaction between rosuvastatin and dronedarone." assertion.